- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Higher efficiency and cost savings with BASF's new NanoSelectTM catalysts for hydrogenation reactions in pharma applications.
BASF Catalysts, the global leader in catalysis, will introduce the first two catalysts from its new NanoSelectTM platform technology, NanoSelect LF 100 and NanoSelect LF 200, for use in fine chemical and pharmaceutical applications at the CPhl Worldwide which starts today.
The two catalysts NanoSelect LF 100 and NanoSelect LF 200 were specifically designed to meet the market requirements of providing a Lead-free replacement for Lindlar catalysts, which have long been used in hydrogenation processes. NanoSelect LF 100 and LF 200 are characterized by supported well-defined, unimodal nano-sized palladium clusters and show similar activity and selectivity as Lindlar catalysts in selective hydrogenation reactions. "BASF NanoSelect LF 100 and LF 200 catalysts are an environmentally-friendly alternative for Lindlar catalysts," says Dr. Hans Donkervoort, Global Product Technology Manager Specialty and Fine Chemicals Catalysts at BASF's Catalyst Division. "They additionally offer significant cost savings by having a markedly lower Precious Metal content."
The Catalysts Division is among a number of BASF businesses presenting their extensive expertise for supporting pharmaceutical industry customers at "CPhI Worldwide," the "Convention on Pharmaceutical Ingredients and Intermediates" that will take place in Frankfurt, Germany, from September 30 through October 2, 2008.
BASF's booth 30B04, in Hall 3.0, will bear the motto "Pharma Solutions from BASF." In addition to catalysts, BASF also presents pharma ingredients and custom synthesis services for better drugs, high-end intermediates for the pharmaceutical industry as well as innovative inorganic specialties.
BASF continually develops new intelligent solutions based on the latest catalyst technologies for its customers. The company delivers these "Enabling Technologies" to the fine chemical, pharmaceutical and agrochemical markets to make its customers more successful in their dynamically changing environments. The portfolio of enabling technologies, including precious metal and base metal hetero- and homogeneous catalysts and metal scavenging materials, is continuously strengthened by focused R&D and licensing of new technologies.
BASF's Catalysts division is the world's leading supplier of environmental and process catalysts. The group offers exceptional expertise in the development of technologies that protect the air we breathe, produce the fuels that power our world and ensure efficient production of a wide variety of chemicals, plastics, adsorbents and other products.
About BASF Catalysts
BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost €58 billion in 2007.BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN).
For more information, please click here
Copyright © BASF CatalystsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Syracuse University chemists add color to chemical reactions: Chemists in the College of Arts and Sciences have come up with an innovative new way to visualize and monitor chemical reactions in real time May 19th, 2016
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016